Cardio-oncology- Tenure Track Faculty
This job is no longer available
There are still lots of open positions. Let's find the one that's right for you.
About The Position
Individuals developing cancer often suffer from co-morbidities that impact the cardiovascular system, influencing their ability to sustain treatment; reciprocally, some therapies for cancer can damage the heart, seriously impacting survivorship. The Department of Cancer and Cellular Biology (DCCB) at the Lewis Katz School of Medicine (LKSOM) at Temple University invites applications from qualified candidates for tenure-track faculty positions focused on Cardio-oncology at the level of Assistant or Associate Professor. Applicants to this research-intensive position are expected to devote primary efforts to performing creative, high-impact studies supported by extramural funding. Translational scientists and physician-scientists seeking hybrid laboratory-clinical appointments are strongly encouraged to apply. The DCCB is a hub of innovative cancer research at the LKSOM, with laboratory space located near to other departments providing broad expertise. Cardiovascular research and cardiovascular medicine are particular strengths at LKSOM; hires to this position would have the opportunity to work closely with researchers in the Aging + Cardiovascular Discovery Center (ACDC), led by Dr. John Elrod, and interact with clinicians in the Department of Medicine, led by Dr. Daniel Edmundowicz, among others in the Department of Cardiovascular Sciences. In addition, DCCB members typically receive secondary appointments at the nearby Fox Chase Cancer Center at Temple Health, an NCI-designated Comprehensive Cancer Center, allowing them to benefit from access to extensive research core facilities at Fox Chase, and interactions with clinical researchers at Fox Chase and Temple Health who lead national clinical trials for cancer and cardiovascular disease. The goal of the DCCB is to conduct interdisciplinary research that leverages the strengths of these exceptional programs, and to serve as a bridge to other outstanding research and clinical initiatives across Temple.
